Targeting HER2 Positive Breast Cancer Cells by Affibody Labeled, Gefitinib Loaded Apoferritin Nanoparticles
dc.contributor.author | Kuruppu, AI | |
dc.contributor.author | Zhang, L | |
dc.contributor.author | Turyanska, L | |
dc.contributor.author | Thomas, N | |
dc.contributor.author | Bradshaw, TD | |
dc.date.accessioned | 2021-10-07T06:01:04Z | |
dc.date.available | 2021-10-07T06:01:04Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | http://ir.kdu.ac.lk/handle/345/4785 | |
dc.language.iso | en | en_US |
dc.subject | Nanoparticles | en_US |
dc.subject | Cancer | en_US |
dc.subject | Targeted therapy | en_US |
dc.title | Targeting HER2 Positive Breast Cancer Cells by Affibody Labeled, Gefitinib Loaded Apoferritin Nanoparticles | en_US |
dc.type | Article Abstract | en_US |
dc.identifier.journal | KDU-IRC 2021 | en_US |
dc.identifier.pgnos | 5 | en_US |